Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Clinical Medicine|April 12, 2022
Imetelstat Induces Leukemia Stem Cell Death in Pediatric Acute Myeloid Leukemia Patient-Derived XenograftsSonali P Barwe, Fei Huang, Edward Anders Kolb, et al.
Chemotherapy|February 28, 2008
The combination of clofarabine and cytarabine in pediatric relapsed acute lymphoblastic leukemia: a case reportPooja Gidwani, K H Ramesh, Yingxian Liu, et al.
Cancers|June 28, 2023
Bone Marrow Microenvironment-Induced Chemoprotection in <i>KMT2A</i> Rearranged Pediatric AML Is Overcome by Azacitidine-Panobinostat CombinationKara M Lehner, Anilkumar Gopalakrishnapillai, Edward Anders Kolb, et al.
Cells|February 25, 2022
Modeling Down Syndrome Myeloid Leukemia by Sequential Introduction of <i>GATA1</i> and <i>STAG2</i> Mutations in Induced Pluripotent Stem Cells with Trisomy 21Sonali P Barwe, Aimy Sebastian, Ishnoor Sidhu, et al.
Cancers|March 25, 2022
Mesothelin: An Immunotherapeutic Target beyond Solid TumorsJoshua R Faust, Darcy Hamill, Edward Anders Kolb, et al.
Journal of Clinical Medicine|March 10, 2022
Efficacy of Flotetuzumab in Combination with Cytarabine in Patient-Derived Xenograft Models of Pediatric Acute Myeloid LeukemiaSonali P Barwe, Anne Kisielewski, Ezio Bonvini, et al.
Cancers|February 15, 2022
Blood Count Recovery Following Induction Therapy for Acute Myeloid Leukemia in Children Does Not Predict SurvivalLauren Pommert, Todd M Cooper, Robert B Gerbing, et al.
Pediatric Blood & Cancer|March 25, 2020
Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing ConsortiumDouglas J Harrison, Jonathan D Gill, Michael E Roth, et al.
Haematologica|February 8, 2020
Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology GroupRichard Aplenc, Soheil Meshinchi, Lillian Sung, et al.
Cancers|December 10, 2021
Immunotherapeutic Targeting of Mesothelin Positive Pediatric AML Using Bispecific T Cell Engaging AntibodiesAnilkumar Gopalakrishnapillai, Colin E Correnti, Kristina Pilat, et al.
Pageof 2